Weintraub Adi Y, Amash Alaa, Eshkoli Tamar, Piltcher Haber Esther, Bronfenmacher Bella, Sheiner Eyal, Holcberg Gershon, Huleihel Mahmoud
Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer Sheva, Israel.
Hypertens Pregnancy. 2013 May;32(2):178-88. doi: 10.3109/10641955.2013.784787.
To evaluate the effect of magnesium sulfate (MgSO(4)) on placental expression levels of vascular endothelial growth factor (VEGF).
Cotyledons of term normotensive and preeclamptic placentas were dually perfused for 6 h, with MgSO(4) (6-7 mg%) in the maternal reservoir [normotensive (n = 3); preeclamptic (n = 4)] and with the control medium (without MgSO(4)) [normotensive (n = 3); preeclamptic (n = 6)]. After perfusion, placental tissue samples were collected from four different placental compartments (amnion, chorion, placental villous and decidua). The collected placental tissues were homogenized and examined for VEGF by ELISA. Statistical significance was determined using a two-way analysis of variance.
After perfusion with control medium, significantly lower levels of VEGF were detected in the chorion and placental villous compartments of preeclamptic placentas (70 ± 24 pg/g protein and 29 ± 11 pg/g protein; respectively), as compared with normotensive placentas (172 ± 80 pg/g protein and 51 ± 17 pg/g protein; respectively; p < 0.05). Exposure of preeclamptic placentas to MgSO(4) resulted in decreased VEGF levels by the amnion (57 ± 26 pg/g protein), as compared with the control group (153 ± 62 pg/g protein) (p < 0.05). On the other hand, MgSO(4) significantly increased VEGF levels by the placental villous and the decidua (58 ± 15 pg/g protein, 70 ± 29 pg/g protein; respectively), as compared with the control group (29 ± 11 pg/g protein, 33 ± 14 pg/g protein; respectively) (p < 0.01, p < 0.05; respectively). Exposure to MgSO(4) did not affect VEGF levels in normotensive placentas.
Reduced levels of VEGF are expressed by some placental compartments in preeclampsia compared with normotensive pregnancy. Perfusion with MgSO(4) affects VEGF expression differently by preeclamptic and normotensive placentas. Increased production of placental VEGF in preeclampsia may play a role in the therapeutic action of MgSO(4).
评估硫酸镁(MgSO₄)对血管内皮生长因子(VEGF)胎盘表达水平的影响。
对足月血压正常和子痫前期胎盘的子叶进行双灌注6小时,母液中加入硫酸镁(6 - 7mg%)[血压正常组(n = 3);子痫前期组(n = 4)],对照组母液中不加硫酸镁(MgSO₄)[血压正常组(n = 3);子痫前期组(n = 6)]。灌注后,从四个不同的胎盘区域(羊膜、绒毛膜、胎盘绒毛和蜕膜)采集胎盘组织样本。将采集的胎盘组织匀浆,采用酶联免疫吸附测定法检测VEGF。采用双向方差分析确定统计学意义。
灌注对照液后,子痫前期胎盘的绒毛膜和胎盘绒毛区域中检测到的VEGF水平显著低于血压正常的胎盘(分别为70±24pg/g蛋白和29±11pg/g蛋白),而血压正常胎盘的相应水平分别为172±80pg/g蛋白和51±17pg/g蛋白(p<0.05)。子痫前期胎盘暴露于硫酸镁后,羊膜中VEGF水平降低(57±26pg/g蛋白),与对照组(153±62pg/g蛋白)相比(p<0.05)。另一方面,与对照组相比(分别为29±11pg/g蛋白和33±14pg/g蛋白),硫酸镁使胎盘绒毛和蜕膜中的VEGF水平显著升高(分别为58±15pg/g蛋白和70±29pg/g蛋白)(分别为p<0.01,p<0.05)。暴露于硫酸镁对血压正常胎盘的VEGF水平无影响。
与血压正常的妊娠相比,子痫前期某些胎盘区域的VEGF表达水平降低。硫酸镁灌注对子痫前期和血压正常胎盘的VEGF表达影响不同。子痫前期胎盘VEGF产生增加可能在硫酸镁的治疗作用中发挥作用。